Citation

BibTex format

@article{Rosivatz:2006:10.1021/cb600352f,
author = {Rosivatz, E and Matthews, JG and McDonald, NQ and Mulet, X and Ho, KK and Lossi, N and Schmid, AC and Mirabelli, M and Pomeranz, KM and Erneux, C and Lam, EW and Vilar, R and Woscholski, R},
doi = {10.1021/cb600352f},
journal = {ACS Chem.Biol.},
pages = {780--790},
title = {A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN)},
url = {http://dx.doi.org/10.1021/cb600352f},
volume = {1},
year = {2006}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Phosphatase and tensin homologue deleted on chromosome 10 (PTEN), a phosphoinositide 3-phosphatase, is an important regulator of insulin-dependent signaling. The loss or impairment of PTEN results in an antidiabetic impact, which led to the suggestion that PTEN could be an important target for drugs against type II diabetes. Here we report the design and validation of a small- molecule inhibitor of PTEN. Compared with other cysteine-based phosphatases, PTEN has a much wider active site cleft enabling it to bind the PtdIns(3,4,5)P3 substrate. We have exploited this feature in the design of vanadate scaffolds complexed to a range of different organic ligands, some of which show potent inhibitory activity. A vanadyl complexed to hydroxypicolinic acid was found to be a highly potent and specific inhibitor of PTEN that increases cellular PtdIns(3,4,5)P3 levels, phosphorylation of Akt, and glucose uptake in adipocytes at nanomolar concentrations. The findings presented here demonstrate the applicability of a novel and specific chemical inhibitor against PTEN in research and drug development
AU - Rosivatz,E
AU - Matthews,JG
AU - McDonald,NQ
AU - Mulet,X
AU - Ho,KK
AU - Lossi,N
AU - Schmid,AC
AU - Mirabelli,M
AU - Pomeranz,KM
AU - Erneux,C
AU - Lam,EW
AU - Vilar,R
AU - Woscholski,R
DO - 10.1021/cb600352f
EP - 790
PY - 2006///
SP - 780
TI - A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN)
T2 - ACS Chem.Biol.
UR - http://dx.doi.org/10.1021/cb600352f
UR - pm:17240976
VL - 1
ER -

ICB logo

Contact us

Project Manager:
Emma Pallett


Director: 
Dr Laura Barter